Associate Professor Jonathan Emberson
BA, MSc, PhD
Associate Professor, Medical Statistics and Epidemiology
- MRC PHRU Programme Leader
- NDPH Deputy Director of Graduate Studies
- Clinical Trial Service Unit
- MSc in Global Health Science Module Lead: Clinical Trials and Meta-Analysis
Jonathan is an Associate Professor of Medical Statistics and Epidemiology within the Nuffield Department of Population Health. After graduating in Mathematics in 1998, he studied statistics and epidemiology at MSc and PhD level before joining the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in 2004.
His main research involves studying the causes and prevention of cardiovascular diseases through the design, conduct and analysis of large-scale observational cohort studies, randomised controlled trials, and individual-participant-data meta-analyses of both types of study. In particular, he is the UK Principal Investigator and MRC Population Health Research Unit (MRC-PHRU) Programme Leader for the Mexico City Prospective Study, a blood-based prospective cohort study of 150,000 Mexican adults followed for more than 15 years.
Adiposity and vascular-metabolic mortality among 150,000 Mexican adults followed for 15 years
GNATIUC L. et al, (2018)
Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study.
Herrington WG. et al, (2018), Lancet Diabetes Endocrinol, 6, 455 - 463
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
3C Study Collaborative Group None., (2018), Am J Transplant, 18, 1424 - 1434
Sex-specific relevance of diabetes to occlusive vascular and other mortality: Meta-analysis of individual data from 68 prospective studies with 77,000 deaths among 1 million adults
Lewington S. et al, (2018), The Lancet Diabetes and Endocrinology
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
Berlanga-Taylor AJ. et al, (2018), EBioMedicine, 31, 133 - 142